UK Startup Funding Report: £398.7m raised across Biotech, AI and Fintech (14–18 Sept 2026).
It's Friday, 18 September, and this is your UK Startup Funding Report.
A busy week of deals saw deep-tech biotech rounds sit alongside major AI and fintech raises. Investors backed both large growth rounds and a raft of early-stage companies across the UK between 14–18 Sept 2026.
Agentic AI moves into enterprise workflows
Agentic and enterprise AI dominated this week’s activity as investors backed companies that connect models to real-world processes. Funding is concentrating on startups that hire agents, run autonomous workflow workers and build human-data layers and skills tooling — all of which push generative systems beyond proofs of concept and into everyday enterprise workflows.
Several sizable rounds underlined that shift. Jack & Jill raised £30 million in a Series A led by Air Street Capital to scale its two-agent hiring marketplace and accelerate US expansion. Magentic secured £13 million led by Felicis to develop autonomous AI agents for procurement and supply-chain workflows at large manufacturers. Resolutiion raised more than £8 million from a syndicate including LocalGlobe and Octopus Ventures to build a risk-to-resolution platform for delivery failures, and AcademyAI closed an oversubscribed £1.7 million pre-seed to deliver skills measurement, AI-generated micro-learning and manager dashboards for enterprises.
Taken together, these bets show investor appetite for applied AI that tightly integrates with corporate data and operations. Early-stage interest in skills tooling and agent-mediated hiring suggests capital is flowing across the stack — from human-data layers to automation. The next phase will be whether founders shift emphasis from product development to US expansion and deeper enterprise integrations.
This week's AI deals:
Jack & Jill raised £30m in a Series A led by Air Street Capital to scale its two-agent hiring marketplace and push further into the US. The funding will support product development, US expansion and growth of the team as the startup commercialises agent‑mediated hiring.
Magentic raised £13m in a round led by Felicis to advance autonomous AI agents that run procurement and supply‑chain workflows. The funding will accelerate product roadmap, enterprise deployments and research into complex optimisation for large manufacturers.
Resolutiion raised more than £8m from a syndicate including LocalGlobe and Octopus Ventures to scale its risk‑to‑resolution platform for commercial disputes. The capital will support product growth as the company helps enterprises detect delivery failures and coordinate multi‑party remediation.
AcademyAI raised £1.7m in an oversubscribed pre‑seed round to build skills measurement and training tools that link generative AI capability to measurable business outcomes. The money will develop assessments, AI‑generated micro‑learning and manager dashboards for enterprise customers.
Grants and VC fuel life sciences scale-up
Diagnostics, drug discovery and biomaterials continued to draw a mix of public and private capital this week. That funding profile helps de-risk the journey from lab to clinic and from prototype to factory, while supporting commercialisation of AI-enabled discovery platforms.
Notable rounds reflected that blend. Chemify secured a £22 million grant package from Scottish Enterprise and the UK Government to expand automated chemistry facilities and scale its Chemify Genesis platform. MicroLub raised £7.5 million to commercialise a protein-based ingredient that replaces fat’s lubricating role, funding trials, supply and international growth. Axo Longevity closed a seed round worth approximately £3.71 million to scale a preventive health membership and expand lab and wearable integrations across Europe, and Eterna Regeneratives closed a seed round led by Hoxton Ventures and The Venture Collective to advance a keratin-based biomaterial for enamel repair and bone regeneration.
These deals illustrate how grants and venture capital work together to lower technical risk and accelerate scale-up. Investors are supporting both platform plays and focused product developers that can move into commercial and clinical partnerships, and funding is geographically spread from Glasgow and Leeds to Cambridge and London.
This week's Biotech & Healthtech deals:
Chemify secured a £22m grant package from Scottish Enterprise and the UK Government to expand automated chemistry facilities and scale its Chemify Genesis discovery platform. The funds will help build a next‑generation Chemifarm and boost lab throughput for molecule and materials discovery.
MicroLub raised £7.5m to commercialise a protein‑based ingredient that replaces fat’s lubricating role, enabling large reductions in fat and calories while retaining mouthfeel. The funding will grow the team, convert trials into commercial supply and support international expansion.
Axo Longevity closed a seed round worth approximately £3.71m (converted from the announced $ figure) to scale its preventive health membership and expand lab and wearable integrations across Europe. The funds will support geographic rollout, clinical partnerships and product development for longitudinal biomarker monitoring.
Eterna Regeneratives closed a seed round led by Hoxton Ventures and The Venture Collective to advance a keratin‑based biomaterial for enamel repair and bone regeneration. The funds will support product development and partnerships targeting oral‑care and regenerative markets.
Regulated rails and aggregation push for scale
Investment continues to favour payments, wealth aggregation and market infrastructure that can operate within regulated frameworks. This week’s deals highlight firms building compliant rails, consumer data aggregation and platforms intended to add liquidity to private credit.
Ryft raised £20 million in a growth round led by Gresham House Ventures to push upmarket, expand across Europe and the US, and scale multi-party payments infrastructure for marketplaces and platforms. Quartz secured £2.8 million in a pre-seed led by Daphni to launch a UK wealth aggregation app and build AISP-compliant data aggregation. Tenka Labs closed a pre-seed led by Maven 11 to develop market infrastructure for origination, placement and secondary trading of asset-backed finance, although the amount was not disclosed.
Taken together, the rounds underline investor interest in firms that can demonstrate regulatory compliance while entering new markets. The next milestones to watch are product launches and cross-border roll-outs that prove these platforms can scale in practice.
This week's Fintech deals:
Ryft raised £20m in a growth round led by Gresham House Ventures to push upmarket and expand across Europe and the US. The capital will fund product development as the Manchester fintech scales its multi‑party payments infrastructure for marketplaces and platforms.
Quartz raised £2.8m in a pre‑seed round led by Daphni to launch its UK wealth aggregation app and build regulatory‑compliant data aggregation. The capital will fund product rollout, user onboarding and AISP‑compliant infrastructure.
Tenka Labs closed a pre‑seed round led by Maven 11 to build market infrastructure for origination, placement and secondary trading of asset‑backed finance. The startup will use the funding to develop platform features, valuation and settlement tools and its planned product launch.
Materials scale-up targets factory readiness
Investors are prioritising materials scale-up and factory diagnostics that reduce waste and reinforce supply chains. The emphasis is on manufacturing-ready materials and tooling that detect defects early, a practical focus for companies aiming to move from lab scale to industrial deployment.
iGii secured £22.7 million to industrialise Gii, a three-dimensional porous carbon nanomaterial, combining equity and public support to accelerate commercial engagement and scale manufacturing capacity. AcouBatt raised £1.1 million to commercialise acoustic sensors and AI for battery formation diagnostics, funding engineering hires, model development and pilot work with battery manufacturers. Both raises target the twin needs of materials scale-up and diagnostic tooling to cut scrap and speed production.
The pattern is clear: funders favour ventures that can plug directly into factories and supply chains, and public support often sits alongside private capital in these capital‑intensive projects. Expect follow-on rounds to focus on piloting at industrial sites and securing early commercial contracts.
This week's Greentech & Advanced Materials deals:
iGii secured £22.7m to industrialise Gii, its three‑dimensional porous carbon nanomaterial, combining equity and public support. The funding will accelerate commercial engagement, product development and scaling of manufacturing capacity for industrial deployments.
AcouBatt raised £1.1m to commercialise acoustic sensors and AI for battery formation diagnostics, aiming to reduce scrap and speed production. The capital will fund engineering hires, model development and pilots with battery manufacturers and test sites.
Satellite manufacturing attracts growth capital
Large growth capital is flowing into end-to-end satellite manufacturing and sovereign space services as governments and enterprises treat space as critical infrastructure. This strategic outlook is driving investment into factories, hardware scale‑up and data services.
Open Cosmos closed a £260 million growth round led by Lightrock to scale satellite manufacturing and expand a suite of sovereign space services across Europe. The capital will fund factories, engineering hires and expansion of offerings such as ConnectedCosmos, OpenConstellation and DataCosmos, reflecting demand for both hardware throughput and AI‑enabled space data services.
The deal signals investor confidence in long-term government and enterprise budgets for space infrastructure. The next phase will be execution: increasing manufacturing throughput and signing the sovereign and commercial contracts that justify large‑scale capacity.
This week's Space / Spacetech deals:
Open Cosmos closed a £260m growth round led by Lightrock to scale satellite manufacturing and expand its suite of sovereign space services across Europe. The capital will fund factories, engineering hires and expansion of its ConnectedCosmos, OpenConstellation and DataCosmos offerings.
🎧 That's this week's Startupmag Weekly Briefing.
See you next Friday for another look at the UK startup scene.